HealthEquity (NASDAQ:HQY) Downgraded to Hold Rating by Wall Street Zen

HealthEquity (NASDAQ:HQY) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

Several other equities analysts have also commented on HQY. Barrington Research restated an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a research report on Friday, May 22nd. Weiss Ratings upgraded shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. Citizens Jmp upped their target price on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. Finally, JPMorgan Chase & Co. dropped their price target on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 18th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $110.57.

HealthEquity Price Performance

Shares of HQY opened at $95.31 on Friday. The company has a market cap of $7.97 billion, a P/E ratio of 35.70, a PEG ratio of 1.60 and a beta of 0.21. The stock has a fifty day moving average price of $86.04 and a 200 day moving average price of $84.67. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. HealthEquity has a 12 month low of $72.76 and a 12 month high of $105.96.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. The firm had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.HealthEquity’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, research analysts forecast that HealthEquity will post 3.92 earnings per share for the current year.

Insider Activity

In related news, Director Gayle Furgurson Wellborn sold 2,439 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the transaction, the director owned 19,733 shares in the company, valued at $1,775,970. This trade represents a 11.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total value of $298,490.00. Following the sale, the executive vice president directly owned 59,113 shares in the company, valued at approximately $5,615,735. The trade was a 5.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 13,081 shares of company stock worth $1,193,000 over the last three months. Corporate insiders own 1.60% of the company’s stock.

Institutional Trading of HealthEquity

A number of hedge funds and other institutional investors have recently modified their holdings of HQY. William Blair Investment Management LLC acquired a new stake in shares of HealthEquity in the fourth quarter valued at $169,956,000. Norges Bank bought a new position in HealthEquity during the fourth quarter valued at about $66,927,000. AQR Capital Management LLC grew its holdings in HealthEquity by 148.5% during the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after acquiring an additional 661,795 shares during the period. Wasatch Advisors LP grew its holdings in HealthEquity by 9.3% during the first quarter. Wasatch Advisors LP now owns 7,202,934 shares of the company’s stock worth $601,949,000 after acquiring an additional 613,288 shares during the period. Finally, Millennium Management LLC grew its holdings in HealthEquity by 151.5% during the fourth quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock worth $87,173,000 after acquiring an additional 573,283 shares during the period. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.